 |
市场调查报告书
商品编码
1529022
鼻腔填塞装置市场，副产品（注射剂、凝胶、喷雾剂、敷料）、类型（可生物吸收、不可吸收）、最终用途（医院、诊所、门诊手术中心、家庭护理场所）- 2024 年至2032 年全球预测Nasal Packing Devices Market, By Product (Injectables, Gels, Sprays, Dressings), Type (Bioresorbable, Non-absorbable), End-use (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings) - Global Forecast 2024 - 2032 |
||||||
由于设备技术的进步和鼻部疾病发生率的上升，2024年至2032年全球鼻腔填充设备市场的复合年增长率将达到5.2%。技术创新提高了鼻腔填塞解决方案的安全性、舒适性和有效性，满足不断变化的患者需求和偏好。此外，鼻窦炎等鼻部疾病病例的增加和术后护理需求的增加，也推动了对先进鼻填塞设备的需求。尖端技术和不断增长的患者群体的结合确保了市场的持续扩张和更有效的鼻部治疗解决方案的发展。
例如，2023 年 7 月，Aptar Pharma 推出了首款无金属鼻喷泵 APF Futurity，旨在输送鼻盐水和类似的 OTC 製剂。这项创新旨在提高鼻腔治疗的安全性和舒适度。这项创新反映了消除金属部件以减少潜在过敏反应并提高用户舒适度的日益增长的趋势。透过专注于无金属设计，Aptar Pharma 解决了安全性和患者体验问题，有可能在市场上树立新标准，并促使竞争对手采用类似的进步。
鼻腔填塞装置产业根据产品、类型、最终用途和地区进行分类。
由于其易用性、患者舒适度和有效性，喷雾剂细分市场到 2032 年将经历显着增长。这些装置可以快速缓解疼痛，并且比传统的鼻填塞方法更不侵入性。喷雾剂受到医疗保健提供者和患者的青睐，因为它们能够将药物直接输送到受影响的区域，减少併发症并促进更快的癒合。鼻部疾病的日益流行和喷雾技术的进步进一步推动了这一领域的主导地位。
在自我管理医疗保健趋势不断增长以及在家治疗鼻部疾病的日益流行的推动下，家庭护理机构细分市场将在 2024 年至 2032 年间大幅增长。患者和照护者正在寻求使用者友好、有效的鼻填塞解决方案，这些解决方案可以在临床环境之外轻鬆实施。居家护理设备的便利性，加上产品设计的进步，提高了可用性和舒适度，正在推动该细分市场的成长，反映出朝向更个人化和易于使用的护理选择的转变。
受国家医疗保健基础设施快速扩张、鼻部健康意识增强以及呼吸系统疾病患病率上升的推动，亚太地区鼻腔填塞设备市场将在 2024 年和 2032 年呈现出可观的复合年增长率。该地区人口众多且多样化，加上对医疗保健技术的投资不断增加和医疗设施的改进，支持了对先进鼻腔填塞解决方案的需求。此外，家庭护理的日益普及和可支配收入的增加也促进了市场的成长，使亚太地区成为鼻腔填塞设备行业的主要贡献者。
目录
第 1 章：方法与范围
第 2 章：执行摘要
第 3 章：产业洞察
- 产业生态系统分析
- 产业影响力
- 成长动力
- 鼻部疾病盛行率增加
- 鼻部手术数量不断增加
- 老化人口基数不断成长
- 重大技术进步
- 产业陷阱与挑战
- 替代方案的可用性
- 与鼻填塞装置相关的副作用
- 成长动力
- 成长潜力分析
- 技术景观
- 监管环境
- 波特的分析
- PESTEL分析
第 4 章：竞争格局
- 介绍
- 公司矩阵分析
- 公司市占率分析
- 战略展望矩阵
第 5 章：市场估计与预测：按产品分类，2021 - 2032 年
- 主要趋势
- 注射剂
- 凝胶
- 喷雾剂
- 敷料
第 6 章：市场估计与预测：按类型，2021 - 2032
- 主要趋势
- 可生物吸收
- 不可吸收
第 7 章：市场估计与预测：按最终用途，2021 - 2032 年
- 主要趋势
- 医院
- 诊所
- 门诊手术中心
- 家庭护理设置
- 其他最终用户
第 8 章：市场估计与预测：按地区，2021 - 2032
- 主要趋势
- 北美洲
- 我们
- 加拿大
- 欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
- 亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
- 中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区
第 9 章：公司简介
- Aegis Lifesciences
- Boston Medical Products Inc.
- Cook
- FABCO
- Fannin Limited
- INNOVIA MEDICAL
- Lohmann & Rauscher GmbH & Co. KG
- Medtronic plc
- Meril Life Sciences Pvt. Ltd.
- Network Medical Products Ltd.
- Olympus Corporation
- Smith & Nephew plc
- Stryker Corporation
- Summit Medical LLC.
- Teleflex Incorporated
Global Nasal Packing Devices Market will record a 5.2% CAGR from 2024 to 2032 due to advancements in device technology and the rising incidence of nasal disorders. Technological innovations enhance the safety, comfort, and efficacy of nasal packing solutions, addressing evolving patient needs and preferences. Also, increasing cases of nasal conditions, such as sinusitis and post-surgical care requirements, fuel demand for advanced nasal packing devices. This combination of cutting-edge technology and a growing patient base ensures continued market expansion and the development of more effective nasal treatment solutions.
For instance, in July 2023, Aptar Pharma introduced its first metal-free nasal spray pump, APF Futurity, designed for delivering nasal saline and similar OTC formulations. This innovation aims to enhance safety and comfort in nasal treatments. This innovation reflects a growing trend toward eliminating metal components to reduce potential allergic reactions and enhance user comfort. By focusing on metal-free design, Aptar Pharma addresses safety and patient experience concerns, potentially setting a new standard in the market and prompting competitors to adopt similar advancements.
The nasal packing devices industry is classified based on product, type, end-use, and region.
The sprays segment will experience marked growth through 2032, attributed to its ease of use, patient comfort, and effectiveness. These devices provide rapid relief and are less invasive than traditional nasal packing methods. Sprays are preferred by both healthcare providers and patients for their ability to deliver medication directly to the affected area, reducing complications and promoting faster healing. The increasing prevalence of nasal disorders and advancements in spray technology further drive this segment's dominance.
The home care settings segment will witness a substantial uptick between 2024 and 2032, propelled by the growing trend towards self-managed healthcare and the increasing prevalence of nasal conditions treated at home. Patients and caregivers are seeking user-friendly, effective nasal packing solutions that can be easily administered outside clinical settings. The convenience of home care devices, coupled with advancements in product design that enhance usability and comfort, is driving this segment's growth, reflecting a shift towards more personalized and accessible care options.
Asia Pacific nasal packing devices market will demonstrate a decent CAGR during 2024 and 2032, spurred by the nation's rapidly expanding healthcare infrastructure, increasing awareness about nasal health, and rising prevalence of respiratory conditions. The region's large and diverse population, along with growing investments in healthcare technology and improvements in medical facilities, supports the demand for advanced nasal packing solutions. Additionally, the increasing adoption of home-based care and rising disposable incomes contribute to market growth, making the Asia Pacific a key contributor to the nasal packing devices industry.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing prevalence of nasal disorders
- 3.2.1.2 Rising number of nasal surgeries
- 3.2.1.3 Growing aging population base
- 3.2.1.4 Significant technological advancements
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Availability of alternatives
- 3.2.2.2 Side effects associated with nasal packing devices
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Technological landscape
- 3.5 Regulatory landscape
- 3.6 Porter's analysis
- 3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Company market share analysis
- 4.4 Strategic outlook matrix
Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Injectables
- 5.3 Gels
- 5.4 Sprays
- 5.5 Dressings
Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Bioresorbable
- 6.3 Non-absorbable
Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Hospitals
- 7.3 Clinics
- 7.4 Ambulatory surgical centers
- 7.5 Home care settings
- 7.6 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
- 9.1 Aegis Lifesciences
- 9.2 Boston Medical Products Inc.
- 9.3 Cook
- 9.4 FABCO
- 9.5 Fannin Limited
- 9.6 INNOVIA MEDICAL
- 9.7 Lohmann & Rauscher GmbH & Co. KG
- 9.8 Medtronic plc
- 9.9 Meril Life Sciences Pvt. Ltd.
- 9.10 Network Medical Products Ltd.
- 9.11 Olympus Corporation
- 9.12 Smith & Nephew plc
- 9.13 Stryker Corporation
- 9.14 Summit Medical LLC.
- 9.15 Teleflex Incorporated
